AAAAAA

   
Results: 1-20 |
Results: 20
HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/mL receiving combination therapy
Authors: Hermankova, M Ray, SC Ruff, C Powell-Davis, M Ingersoll, R D'Aquila, RT Quinn, TC Siliciano, RF Persaud, D
Citation: M. Hermankova et al., HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/mL receiving combination therapy, J AM MED A, 286(2), 2001, pp. 196-207
The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site
Authors: Buck, CB Shen, XF Egan, MA Pierson, TC Walker, CM Siliciano, RF
Citation: Cb. Buck et al., The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site, J VIROLOGY, 75(1), 2001, pp. 181-191
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution
Authors: Blankson, JN Gallant, JE Siliciano, RF
Citation: Jn. Blankson et al., Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution, J INFEC DIS, 183(4), 2001, pp. 657-661
MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy
Authors: Blankson, JN Siliciano, RF
Citation: Jn. Blankson et Rf. Siliciano, MHC class II genotype and the control of viremia in HIV-1-infected individuals on highly active antiretroviral therapy, J CLIN INV, 107(5), 2001, pp. 549-551
Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy
Authors: Pierson, T McArthur, T Siliciano, RF
Citation: T. Pierson et al., Reservoirs for HIV-1: Mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy, ANN R IMMUN, 18, 2000, pp. 665-708
Interleukin 2 treatment for HIV infection
Authors: Blankson, J Siliciano, RF
Citation: J. Blankson et Rf. Siliciano, Interleukin 2 treatment for HIV infection, J AM MED A, 284(2), 2000, pp. 236-238
Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr
Authors: Shen, AD Siliciano, JD Pierson, TC Buck, CB Siliciano, RF
Citation: Ad. Shen et al., Establishment of latent HIV-1 infection of resting CD4(+) T lymphocytes does not require inactivation of Vpr, VIROLOGY, 278(1), 2000, pp. 227-233
AIDS - Preventing AIDS but not HIV-1 infection with a DNA vaccine
Authors: Shen, XF Siliciano, RF
Citation: Xf. Shen et Rf. Siliciano, AIDS - Preventing AIDS but not HIV-1 infection with a DNA vaccine, SCIENCE, 290(5491), 2000, pp. 463
A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions
Authors: Gupta, K Ott, D Hope, TJ Siliciano, RF Boeke, JD
Citation: K. Gupta et al., A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions, J VIROLOGY, 74(24), 2000, pp. 11811-11824
Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1
Authors: Pierson, T Hoffman, TL Blankson, J Finzi, D Chadwick, K Margolick, JB Buck, C Siliciano, JD Doms, RW Siliciano, RF
Citation: T. Pierson et al., Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1, J VIROLOGY, 74(17), 2000, pp. 7824-7833
Biphasic decay of latently infected CD4(+) T cells in acute human immunodeficiency virus type 1 infection
Authors: Blankson, JN Finzi, D Pierson, TC Sabundayo, BP Chadwick, K Margolick, JB Quinn, TC Siliciano, RF
Citation: Jn. Blankson et al., Biphasic decay of latently infected CD4(+) T cells in acute human immunodeficiency virus type 1 infection, J INFEC DIS, 182(6), 2000, pp. 1636-1642
Latency and viral persistence in HIV-1 infection
Authors: Siliciano, JD Siliciano, RF
Citation: Jd. Siliciano et Rf. Siliciano, Latency and viral persistence in HIV-1 infection, J CLIN INV, 106(7), 2000, pp. 823-825
A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children
Authors: Persaud, D Pierson, T Ruff, C Finzi, D Chadwick, KR Margolick, JB Ruff, A Hutton, N Ray, S Siliciano, RF
Citation: D. Persaud et al., A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children, J CLIN INV, 105(7), 2000, pp. 995-1003
Latent infection of CD4(+) T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy
Authors: Finzi, D Blankson, J Siliciano, JD Margolick, JB Chadwick, K Pierson, T Smith, K Lisziewicz, J Lori, F Flexner, C Quinn, TC Chaisson, RE Rosenberg, E Walker, B Gange, S Gallant, J Siliciano, RF
Citation: D. Finzi et al., Latent infection of CD4(+) T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy, NAT MED, 5(5), 1999, pp. 512-517
Latent reservoirs for HIV-1
Authors: Blankson, J Persaud, D Siliciano, RF
Citation: J. Blankson et al., Latent reservoirs for HIV-1, CURR OPIN I, 12(1), 1999, pp. 5-11
An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines
Authors: Carruth, LM Greten, TF Murray, CE Castro, MG Crone, SN Pavlat, W Schneck, JP Siliciano, RF
Citation: Lm. Carruth et al., An algorithm for evaluating human cytotoxic T lymphocyte responses to candidate AIDS vaccines, AIDS RES H, 15(11), 1999, pp. 1021-1034
Latency and reservoirs for HIV-1
Authors: Siliciano, RF
Citation: Rf. Siliciano, Latency and reservoirs for HIV-1, AIDS, 13, 1999, pp. S49-S58
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir
Authors: Lori, F Jessen, H Lieberman, J Finzi, D Rosenberg, E Tinelli, C Walker, B Siliciano, RF Lisziewicz, J
Citation: F. Lori et al., Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir, J INFEC DIS, 180(6), 1999, pp. 1827-1832
Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: Dependence on TAP1/2 and mechanisms for cytosolic localization
Authors: Ferris, RL Hall, C Sipsas, NV Safrit, JT Trocha, A Koup, RA Johnson, RP Siliciano, RF
Citation: Rl. Ferris et al., Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: Dependence on TAP1/2 and mechanisms for cytosolic localization, J IMMUNOL, 162(3), 1999, pp. 1324-1332
Cutting edge: Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen
Authors: Tobery, T Siliciano, RF
Citation: T. Tobery et Rf. Siliciano, Cutting edge: Induction of enhanced CTL-dependent protective immunity in vivo by N-end rule targeting of a model tumor antigen, J IMMUNOL, 162(2), 1999, pp. 639-642
Risultati: 1-20 |